| |
| | LAM Pharmaceutical Executes a Binding Letter of Intent to Acquire Selected Assets of Actium Pharmaceuticals |
 | | Under the terms of the signed Letter of Intent, LAM Pharmaceutical will acquire Actium's FORTEX(R) rubbing oil and acetaminophen products, associated patents, trademarks, customer and distributor lists, accounts receivable and inventory, assignment of distribution and sales agreements, and existing manufacturing capabilities. |
 | | Michel Lockhart, CEO of Actium Pharmaceuticals, and Anthony Jeffers, Vice President of Actium Pharmaceuticals, will be engaged as LAM Pharmaceutical sales and marketing consultants. |
 | | "Actium has a complementary product line with its OTC powerful topical analgesic and its new technology for the novel delivery of acetaminophen. |
| www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/02-04-2003/0001884449&EDATE= (569 words) |
|